Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: A meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4154-4159

  Regina Castro, M ^a,b,c   Caraballo, Pedro J ^a,b,c   Morris, John C ^a,b,c  

^a VA Healthcare Network Upstate New York   (United States)

^b MAYO CLINIC   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; BONE DISEASE; CARDIOVASCULAR DISEASE; CELL HETEROGENEITY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; THYROID HORMONE RELEASE; THYROID NODULE; TREATMENT PLANNING; TUMOR VOLUME;

EID: 0036738516     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-011762     Document Type: Article

References (26)

1. Astwood E, Cassidy C, Aurchbach G 1960 Treatment of goiter and thyroid nodules with thyroid. JAMA 174:459-464
2. Schneeberg N, Stahl T, Maldia G, Menduke H 1962 Regression of goiter by whole thyroid or triiodothyronine. Metabolism 11:1054-1060
3. Shimaoka K, Sokal J 1974 Suppressive therapy of non-toxic goiter. Am J Med 57:576-583
4. Gharib H, James EX, Charboneau JW, Naessens JM, Offord KP, Gorman CA 1987 Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70-75
5. Reverter J, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A 1992 Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25-28
6. Papini E, Bacci V, Panunzi C, Pacella C, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, La Medica P, Masala M, Pitaro M, Nardi F 1993 A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 38:507-513
7. Larijani B, Pajouhi M, Bastanhagh M, Sadjadi A, Sedighi N, Eshraghian M 1999 Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double blind placebo-controlled clinical trial. Endocr Pract 5:251-256
8. Celani M, Mariani M, Mariani G 1990 On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign, solitary, solid or predominantly solid, thyroid nodules. Acta Endocrinol 123:603-608
9. Morita T, Tamai H, Ohshima A, Komaki G, Matsubayashi S, Kuma K, Nakagawa T 1989 Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules. J Clin Endocrinol Metab 69:227-230
10. Uzzan B, Campos J, Cucherat M, Nony P, Boissel J, Perret G 1996 Effects of bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278-4289
11. Faber J, Galloe A 1994 Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350-355
12. Franklin J, Betteridge J, Daykin J, Holder R, Oates G, Parle J, Lilley J, Heath D, Sheppard M 1992 Long-term thyroxine treatment and bone mineral density. Lancet 340:9-13
13. Sawin C, Geller A, Wolf P, Belanger AJ, Baker E, Bacharach P, Wilson P, Benjamin E, D'Agostino R 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252
14. Papini E, Petruci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabrini R, Pacella C 1998 Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780-783
15. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Mediros-Neto G 1997 Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691-697
16. DerSimonian R, Laird N 1986 Meta-analysis in clinical trials. Control Clin Trials 7:177-188
17. Pocock S, Hughes M 1990 Estimation issues in clinical trials and overviews. Stat Med 9:657-671
18. La Rosa G, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A 1995 Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1-8
19. Zelmanovitz F, Genro S, Gross J 1998 Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881-3885
20. Cheung P, Lee J, Boey J 1989 Thyroxine suppressive therapy o f benign solitary thyroid nodules: a prospective randomized study. World J Surg 13:818-821
21. Berghout A, Wiersinga W, Drexhage H, Smits N, Touber J 1990 Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goiter. Lancet 336:193-197
22. Mainini E, Martinelli I, Morandi G, Villa S, Stefani I, Mazzi C 1995 Levothyroxine suppressive therapy for solitary thyroid nodules. J Endocrinol Invest 18:796-799
23. La Rosa G, Ippolito A, Lupo L, Cercabene G, Santonocito M, Vigneri R, Belfiore A 1996 Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 81:4385-4387
24. McCowen K, Reed J, Fariss B 1980 The role of thyroid therapy in patients with thyroid cysts. Am J Med 68:853-855
25. Jarlov A, Hegedus L, Gjorup T, Hansen J 1991 Observer variation in the clinical assessment of the thyroid gland. J Intern Med 229:159-161
26. Carrol BA 1982 Asymptomatic thyroid nodules incidental sonographic detection. Am J Roentgenol 138:499-502